RHU ALBUMIN MARKET ANALYSIS

rHu Albumin Market, by Source (Oryza sativa, Pichia pastoris, Others ), by Application (Cell Culture Media (Nutrient and stabilizer, Medium Supplement), Stem Cell Therapy, Drug Formulations, Cryopreservation, and Others), by End User (Pharmaceutical and Biotechnological Industry, Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022
Code : CMI5040
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Rhu Albumin MarketSize and Trends

The Global rHu Albumin Market is estimated to be valued at US$ 84.9 Mn in 2022, and is expected to exhibit a CAGR of 10.0 % over the forecast period (2022-2030).

Increasing number of clinical trials and research in rHu albumin is expected to drive growth of the global rhu albumin market over the forecast period.

To alleviate the numerous problems associated with standard albumin procurement methods, recombinant human albumin was developed
The recombinant product is favored due to factors such as absence of animal material, reliable supply, higher purity, absence of host-derived proteases, high homogeneity, higher free thiol content, absence of known or unknown human pathogens, batch-to-batch consistency, and presence of a reputable regulatory pathway
Recombinant albumin in drug formulation has been reported to prevent surface adsorption, aggregation, fibrillation, and oxidation
Moreover, introduction of recombinant human albumin — an animal-free, cGMP raw material with high consistency and purity, into the field of stem cell cultivation has improved the definition and control of culture media. These media are favored by regulatory bodies because they provide comprehensive quality data for all constituents, in addition to allowing for improved cell growth repeatability.